Promoting research partnerships to improve veterans’ health

NAVREF is proud to recognize Cohen Veterans Bioscience as our Champion Sponsor


CURRENT IPC MEMBERS

Cohen Veterans Bioscience
Siemens Healthineers
Janssen
Candel Therapeutics
Eisai
Tonix Pharmaceuticals
Mirati Therapeutics
Illumina
Exact Sciences
Genentech
Edwards Lifesciences
Pfizer

As the only association working closely with the Department of Veterans Affairs' research, NAVREF bridges the gap between industry partners and our unique membership of VA-Affiliated Nonprofit Research and Education Foundations. These foundations provide a conduit to the largest and most deserving patient base in the United States. However, there are veterans in search of cutting edge healthcare that are faced with obstacles in need of change. This is where the NAVREF Industry Partner Consortium plays a role. 

The NAVREF Industry Partner Consortium (IPC) is a platform for industry sponsors, nonprofit organizations, and other external stakeholders to identify, collaborate, and overcome challenges within VA research that hinder our nation's veterans from accessing some of the finest and most cutting edge healthcare available. The IPC represents stakeholders from all facets of the healthcare industry representing pharmaceuticals, medical technology, nonprofit foundations, and other organizations with an interest to further veterans research.  

The IPC Mission and Charter

Born from the ACT for Veterans Initiative (Access to Clinical Trials), the Industry Partner Consortium was established to tackle the challenges facing industry partners from delivering quality clinical trials to our nations' veterans.

The mission is to provide a platform to identify barriers and develop solutions facing veterans' access to clinical trials through the collaboration of industry sponsors, nonprofit organizations, and other stake holders interested in supporting VA Research.

The full IPC Charter can be found here.

Interested in the IPC?

IPC Membership is annual and begins at the beginning of the calendar year (January 1). Organizations interested in joining the IPC can fill out a membership application found below.

JOIN OR RENEW YOUR MEMBERSHIP 


Membership Benefits:

  • Navigate the complexities of collaborating with the VA Research Enterprise
  • Insight into Veterans' research needs and understand aligning opportunities
  • Participate in a platform that offers networking interactions, education, and an exchange of cross-organizational information
  • Quarterly stakeholder meetings

Upcoming Events

IPC News and Updates

  • 19 Dec 2022 12:15 PM | Anonymous member (Administrator)

    Written by: Priscilla West, MPH

    The NAVREF Industry Partner Consortium (IPC) held three meetings during the past year.  An Executive Committee for the IPC was developed to help focus and prioritize the broad interests of the group.  The charter members of the Executive Committee include: Peggy Bradley (Executive Director, Biomedical Research and Education Foundation of Southern Arizona), Angie Smith (Executive Director, North Florida Foundation for Research and Education), Caroline Zink (Executive Director, Baltimore Research and Education Foundation), Sean Cunningham (Janssen), Theresa Devens (Eisai), and Allyson Gage (Cohen Veterans Bioscience).

    At the most recent IPC meeting in Miami on December 6-7, conversations continued about decentralized clinical trials (DCTs), and how they might best work for VA sites.  Decentralized clinical trials are characterized by less dependence on traditional clinical research infrastructure, and more on virtual communication tools like telemedicine, patient-driven communication devices, home health visits (or visits at ancillary facilities closer to the patient’s home), and direct mailing of study medications and other study materials to the patient’s home.  The Covid pandemic led to strong interest in developing DCT methods, and the IPC is discussing how some of these methods might improve veteran access to clinical trials and their satisfaction with the research experience. 

    The IPC Miami meeting also included a discussion about consistent access to VA data to provide support to NAVREF members, VA researchers and clinical trial sponsors in the following areas:

    • ·        Identification of prospective study sites for new or expanding studies
    • ·        Prescreening potential study subjects for existing studies

    We will move forward with contracting with the VINCI program to provide these services for NAVREF members.  During the first year, it will be important to establish the level and scope of demand so that we can best tailor services for future years. 

    Our IPC industry colleagues identified the need for a VA clinical trial ‘Playbook,’ describing the VA processes for reviewing and approving clinical research in lay terms (including a dictionary of VA research-related acronyms).  A big thank you to Katrina Washburn (Executive Director of the South Florida Veterans Affairs Foundation for Research and Education), who volunteered to take the lead on drafting this document.

    The Miami IPC meeting wrapped up with a discussion about how we can best support diversity and equity in VA clinical trials, including gender, race, and geographic distribution/rurality of study subjects.  Industry partners noted that the US Food and Drug Administration also has strong interests in promoting equal access to clinical studies.  There was unanimous support for this effort, and we will be reaching out to other government and nonprofit agencies to assist us in developing effective strategies to strengthen equity in clinical trials access and participation.


  • 22 Jul 2022 3:33 PM | Anonymous member (Administrator)
    Dedicated to all the Veterans willing to continue service to their nation through research.

Disclosures

The members intend to conduct their affairs in compliance with the antitrust laws of the United States, the states within the United States and the antitrust/competition laws of other countries. The representatives will not:

  • § Discuss prices or pricing policies nor practices;
  • § Discuss markets in which to compete;
  • § Discuss raw materials, product, equipment, services or other supplies from any supplier or vendor;
  • § Attempt to prevent any person from gaining access to any market or customer for goods and services or obtaining a supply of goods or services freely in the market; or
  • § Deny any application for participation, which meets the qualifications therefor, participation in the Association for any anti-competitive purpose.

1717 K ST NW Suite 900

Washington, DC 20006

202-951-7701  |  admin@navref.org

FEIN: 52-1784596

Powered by Wild Apricot Membership Software